CP
AGIO icon

CenterBook Partners’s Agios Pharmaceuticals AGIO Stock Holding History

CenterBook Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812K Buy
21,885
+4,440
+25% +$135K 0.04% 403
2026
Q1 		$590K Buy
+17,445
New +$495K 0.03% 453
2025
Q3 		– Sell
-243,063
Closed -$8.08M – 550
2025
Q2 		$8.08M Buy
243,063
+134,554
+124% +$4.08M 0.45% 48
2025
Q1 		$3.18M Sell
108,509
-197,090
-64% -$6.54M 0.2% 134
2024
Q4 		$10M Buy
305,599
+151,511
+98% +$7.12M 0.6% 35
2024
Q3 		$6.85M Sell
154,088
-95,223
-38% -$4.32M 0.42% 72
2024
Q2 		$10.8M Buy
+249,311
New +$9M 0.67% 24

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

CenterBook Partners's AGIO Position: Q2 2026 in Review

CenterBook Partners increased its Agios Pharmaceuticals (AGIO) stake by 25% in Q2 2026, buying an estimated $135K and bringing the position to 21,885 shares worth $812K. The position accounts for 0.04% of the portfolio, ranked #403.

CenterBook Partners first reported a position in AGIO in Q2 2024 and has held it in 7 quarters since. The position peaked at $10.8M in Q2 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • CenterBook Partners held 21,885 shares of Agios Pharmaceuticals worth $812K as of Q2 2026.
  • CenterBook Partners bought 4,440 Agios Pharmaceuticals shares in Q2 2026, an estimated $135K.
  • Agios Pharmaceuticals made up 0.04% of CenterBook Partners's portfolio in Q2 2026, its #403 holding.
  • CenterBook Partners first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • CenterBook Partners's Agios Pharmaceuticals position peaked at $10.8M in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.